CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Chief Medical Officer sold 28,002 shares at an average $60.09 ($1,682,554)
- 4 Open-market sale Chief Medical Officer sold 10,943 shares at an average $60.05 ($657,171)
- 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
- 4 Gift Director gave 3,415 shares (gift)
- 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Commercial Officer sold 3,462 shares at $55.41 ($191,829)
- 4 Open-market sale Chief Medical Officer sold 17,611 shares at an average $55.12 ($970,636)
- 4 Open-market sale Principal Accounting Officer sold 1,118 shares at $55.89 ($62,485)
- 4 Open-market sale Principal Accounting Officer sold 991 shares at $54.00 ($53,514)
Page 14 of 38 · 758 filings